DIABETIC AUTONOMIC POLYNEUROPATHY
- Авторлар: Kotova O.V.1, Kotova OV1
-
Мекемелер:
- Шығарылым: № 6 (2012)
- Беттер: 40-44
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279446
- ID: 279446
Дәйексөз келтіру
Толық мәтін
Аннотация
Diabetic autonomic neuropathy (DAN) is a common complication of diabetes affecting negatively both on survival and quality of life of patients with diabetes mellitus. Based on testing of vegetative status, the prevalence of DAN varies from 7.7 to 90%. DAN may affect all organs and systems, or only some of them. A series of tests, including, in particular, evaluation of cardiovascular reflexes, are used for the diagnosis of DAN. In the treatment of DAN, administration of thiamine-containing drugs, such as Trigamma, is reasonable.
Негізгі сөздер
Әдебиет тізімі
- Valensi P, Huard JP, et al. Factors involved in cardiac autonomic neuropathy in diabetic patients. J Diabetes Complicat 1997;11:180-87.
- The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 1998;41:416-23.
- Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 2001;68:928-30.
- Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-24.
- Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-79.
- Neil HA, Thompson AV, John S, et al. Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population. Diabet Med 1989;6:20-4.
- Ziegler D, Gries FA, Spuler M, Lessmann F. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group: The epidemiology of diabetic neuropathy. J Diabetes Complicat 1992;6:49-57.
- O'Brien IA, O'Hare JP, Lewin IG, Corrall RJ: The prevalence of autonomic neuropathy in insulin-dependent diabetes: a controlled study based on heart rate variability. Q J Med 1986;61:957-67.
- Verrotti A, Chiarelli F, Blasetti A, Morgese G. Autonomic neuropathy in diabetic children. J Paediatr Child Health 1995;31:545-48.
- Филиппов Ю.А. Гастроэнтерологические нарушения при диабетической невропатии // Врач 2011. № 4. С. 96-101.
- Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980;92:301-3.
- Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491-98.
- Young MJ, Marshall A, Adams JE, et al. Osteopenia, neurological dysfunction, and the development of charcot neuroarthropathy. Diabetes Care 1995;18:34-8.
- Балаболкин М.И., Чернышова Т.Е., Трусов В.В., Гурьева И.В. Диабетическая невропатия: патогенез, диагностика, классификация, прогностическое значение, лечение: Учебно-методическое пособие. М., 2003. 105 с.
- Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 1994;10:339-83.
- Ryle C, Donaghy M. Non-enzymatic glycation of peripheral nerve proteins in human diabetics. J Neurol Sci 1995;129(1):62-8.
- Peppa M, Uribarri J, Vlassara H. Glucose, Advanced Glycation End Products, and Diabetes Complications: What Is New and What Works. Clinical Diabetes 2003;21(4):186-87.
- Booth AA, Khalifah RG, Hudson BG. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison witn aminoguanidine. Biochem Biophys Res Comm 1996;220:113-19.
- M la Selva, et al. Thiamine corrects delayed replication and decreased production of lactate and advanced glycation endproducts in bovine retinal and umbilical vein endothelial cells cultured under high-glucose conditions. Diabetologia 1996;39:1263-8.
- Thornalley P, Babaei-Jadidi R, Al Ali H,
Қосымша файлдар
